Clinical trials
Phase 1 Hyperlipidemias trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 3 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Recruiting | 2 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 5 |
| AstraZeneca | 2 |
| Kowa Research Institute, Inc. | 2 |
| Amgen | 1 |
| Avera McKennan Hospital & University Health Center | 1 |
| Eli Lilly and Company | 1 |
| HanAll BioPharma Co., Ltd. | 1 |
| Hoskinson Health and Wellness Clinic | 1 |
| NYU Langone Health | 1 |
| National Institutes of Health Clinical Center (CC) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipidemias | 27 |
| Dyslipidemias | 5 |
| Hypercholesterolemia | 5 |
| Cardiovascular Diseases | 4 |
| Hypertension | 4 |
| Obesity | 3 |
| Insulin Resistance | 2 |
| Lipid Metabolism Disorders | 2 |
| Metabolic Diseases | 2 |
| Metabolic Syndrome | 2 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.